XBiotech (XBIT)

• Market cap: $75.9M
• 1 day: 0%
• 5 days: -2.35%
• 1 month: -6.74%
• 3 months: -17%
• 6 months: -15.31%
• Year to date: -40.29%
• 1 year: -66.98%
• 5 years: -86.59%
• 10 years: -82.3%
• Sector: Healthcare
• Industry: Biotechnology

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 92